Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Neurochem. 2015 Jun 1;134(3):463–470. doi: 10.1111/jnc.13152

Figure 6.

Figure 6

Schematic mechanism of action of rosiglitazone-activated PPARγ in neuroprotection. Rosiglitazone enters the nucleus and binds PPARγ. The activated PPARγ binds the NF-α1 promoter to activate transcription. The NF-α1 mRNA is consequently translated and the protein is secreted. It then binds a cognate receptor and activates the ERK and AKT pathways leading to an increase in BCL-2 expression which mediate neuroprotection by inhibition of caspases.